D. Prusty

发表

High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment

V. Prajapati, Rupal Ojha, Nidhi Gupta, 2020, International Journal of Biological Macromolecules.

Identification of antiviral peptide inhibitors for receptor binding domain of SARS-CoV-2 omicron and its sub-variants: an in-silico approach

B. Naik, D. Prusty, H. Banavath, 2022, 3 Biotech.

Identification of antiviral peptide inhibitors for receptor binding domain of SARS-CoV-2 omicron and its sub-variants: an in-silico approach

B. Naik, D. Prusty, H. Banavath, 2022, 3 Biotech.

Rational designing of peptide-ligand conjugates-based immunotherapy for the treatment of complicated malaria.

V. Prajapati, Rupal Ojha, B. Naik, 2022, Life sciences.

Chemical system biology approach to identify multi-targeting FDA inhibitors for treating COVID-19 and associated health complications

Pundarikaksha Das, V. S. Mattaparthi, V. Prajapati, 2021, Journal of biomolecular structure & dynamics.

Strategic Development of a Next-Generation Multi-Epitope Vaccine To Prevent Nipah Virus Zoonotic Infection

V. Prajapati, R. Pandey, Rupal Ojha, 2019, ACS omega.

The Role of Palmitoylation for Protein Recruitment to the Inner Membrane Complex of the Malaria Parasite*

L. S. Swapna, J. Parkinson, T. Gilberger, 2014, The Journal of Biological Chemistry.

Potent Antimalarial Activity of Acriflavine In Vitro and In Vivo

T. Adak, Ashraf Dar, S. Dhar, 2014, ACS chemical biology.

The domain structure of Helicobacter pylori DnaB helicase: the N-terminal domain can be dispensable for helicase activity whereas the extreme C-terminal region is essential for its function

Samudrala Gourinath, Suman Kumar Dhar, Subhankar Paul, 2007, Nucleic acids research.

High throughput and comprehensive approach to develop multiepitope vaccine against minacious COVID-19

V. Prajapati, Rupal Ojha, Nidhi Gupta, 2020, European Journal of Pharmaceutical Sciences.

Receptor-ligand based molecular interaction to discover adjuvant for immune cell TLRs to develop next-generation vaccine.

A. Mishra, V. Prajapati, Nidhi Gupta, 2020, International journal of biological macromolecules.

Structural basis of fitness of emerging SARS-COV-2 variants and considerations for screening, testing and surveillance strategy to contain their threat.

S. Islam, S. Manna, D. Prusty, 2021, medRxiv.

Single-stranded DNA binding protein from human malarial parasite Plasmodium falciparum is encoded in the nucleus and targeted to the apicoplast.

Ashraf Dar, S. Dhar, Atul Sharma, 2010, Nucleic acids research.

A Unique 45-Amino-Acid Region in the Toprim Domain of Plasmodium falciparum Gyrase B Is Essential for Its Activity

N. Mondal, Ashraf Dar, S. Dhar, 2009, Eukaryotic Cell.

Nicotinamide inhibits Plasmodium falciparum Sir2 activity in vitro and parasite growth.

Amol V. Shivange, A. Gupta, S. Dhar, 2008, FEMS microbiology letters.

Identification of FDA-approved drugs with triple targeting mode of action for the treatment of monkeypox: a high throughput virtual screening study

V. S. Mattaparthi, B. Naik, D. Prusty, 2023, Molecular diversity.

The apicomplexan inner membrane complex.

J. Parkinson, T. Gilberger, M. Kono, 2013, Frontiers in bioscience.

Asymptomatic malaria infection prevailing risks for human health and malaria elimination.

Arun Prakash Upadhyay, V. Prajapati, Ashraf Dar, 2021, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Chapter 17 Future of system vaccinology

D. Prusty, 2022, System Vaccinology.

Structure-based virtual screening approach reveals natural multi-target compounds for the development of antimalarial drugs to combat drug resistance.

Rajanish Giri, Prateek Kumar, V. Prajapati, 2023, Journal of biomolecular structure & dynamics.

The Role of Palmitoylation for Protein Recruitment to the Inner Membrane Complex of the Malaria Parasite*

L. S. Swapna, J. Parkinson, T. Gilberger, 2014, The Journal of Biological Chemistry.

Peptide-ligand conjugate based immunotherapeutic approach for targeted dismissal of non-structural protein 1 of dengue virus: A novel therapeutic solution for mild and severe dengue infections

B. Naik, Satyendra Singh, D. Prusty, 2024, International Journal of Biological Macromolecules.

Nicotinamide inhibits Plasmodium falciparum Sir2 activity in vitro and parasite growth.

Amol V. Shivange, A. Gupta, S. Dhar, 2008, FEMS microbiology letters.

Molecular docking, MD simulation, and MMGBSA-binding free energy estimation study identify antibiotic analogs as potential antimalarials targeting housekeeping proteins of Plasmodium falciparum apicoplast

B. Naik, D. Prusty, 2024, Molecular Simulation.